This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Non-Myeloablative Transplant

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What a Non-Myeloablative Transplant Means

A non-myeloablative transplant, also called a mini-transplant or reduced-intensity transplant, is a type of donor stem cell transplant that uses lower doses of chemotherapy and/or radiation therapy than a standard transplant. Unlike traditional transplants that use very high doses to destroy all of the patient’s bone marrow and cancer cells, this gentler approach does not completely wipe out the patient’s bone marrow. Instead, it weakens the immune system enough to prevent it from rejecting the donor’s stem cells. After the transplant, both the patient’s and donor’s stem cells live in the body for a time. Eventually, the donor’s stem cells grow and replace the patient’s bone marrow, helping restore healthy blood cell production and fight remaining cancer cells.

Why This Transplant Option Matters in Cancer Care

Non-myeloablative transplants can be an important option for people who might not tolerate the intense treatment of a standard transplant. This includes older adults or those with other health problems that make full-dose transplants too risky. By using lower doses of chemotherapy or radiation, this approach aims to reduce some of the severe side effects and complications that come with stronger treatments. In certain blood cancers like leukemia, the donor’s cells can also help attack leftover cancer cells through a process called graft-versus-leukemia effect, which may improve treatment success.

What Patients Might Experience or Hear

If your care team discusses a non-myeloablative transplant, they may explain that it involves receiving donor stem cells after milder chemotherapy or radiation. You might hear about the importance of matching donor cells closely to reduce risks like graft-versus-host disease, where donor cells attack your body’s tissues. Side effects can include feeling tired, increased risk of infections, nausea, mouth sores, and longer-term issues such as infertility or organ damage. Because both your own and donor stem cells coexist for a time, close medical follow-up is needed to monitor recovery and manage side effects.

Where You Might See This Term

The term non-myeloablative transplant may appear in medical reports, treatment plans, clinical trial descriptions, or discussions about stem cell transplants. It is also called mini-transplant or reduced-intensity transplant. Seeing these different names can be confusing, so it’s helpful to ask your care team how the term applies to your specific treatment.

What This Term Does Not Automatically Mean

Hearing the term non-myeloablative transplant does not mean a diagnosis or guarantee a specific treatment plan. It describes a transplant approach that may or may not be suitable depending on individual health, cancer type, and other factors. It also does not mean the treatment has no risks or side effects—there can still be serious complications that require careful management.

Common Questions to Ask Your Care Team

When you hear about a non-myeloablative transplant, you might ask: How does this transplant differ from a standard one? What are the risks and benefits for me? How closely do donor cells need to match? What side effects should I expect? How will my recovery be monitored? Understanding these details can help you feel more informed and prepared.

Reading the Term in Context and Safety Notes

This glossary entry is educational and does not decide what is safe, appropriate, or effective for any individual patient. If the term appears in a medical record or treatment plan, the safest next step is to ask your care team what it means in that exact context. Every person’s situation is different, so it’s important to understand how this treatment fits your unique health needs.

Next Steps for Patients and Caregivers

If you come across the term non-myeloablative transplant, mini-transplant, or reduced-intensity transplant, the best next step is to talk openly with your healthcare team. They can explain how this treatment option might apply to your care, what to expect, and how to prepare. Being informed helps you make decisions that feel right for you and your health journey.

Sources

Public source information used for this glossary entry includes: